Tg Therapeutics (TGTX) Treasury Shares (2012 - 2026)

Tg Therapeutics' Treasury Shares history runs 15 years deep, the most recent figure standing at $200.2 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 3169.64% year-over-year to $200.2 million; the TTM figure through Mar 2026 stood at $200.2 million (up 3169.64% YoY), while the FY2025 annual figure was $100.2 million, up 1013.71% from the prior year.
• Treasury Shares for Q1 2026 stood at $200.2 million, up from $100.2 million in the prior quarter.
• The five-year high for Treasury Shares was $12.9 million in Q1 2025, with the low at $41309.0 in Q3 2022.
• The 5-year median for Treasury Shares is $9.6 million (2023), against an average of $8.3 million.
• The sharpest annual moves came in 2022 and 2025: Treasury Shares changed 0.0% in 2022, then surged 4562.63% in 2025.
• Tg Therapeutics' Treasury Shares stood at $234000.0 in 2022, then changed by 0.0% to $234000.0 in 2023, then surged by 3746.15% to $9.0 million in 2024, then jumped by 1013.71% to $100.2 million in 2025, then surged by 99.73% to $200.2 million in 2026.
• Business Quant data shows TGTX's Treasury Shares at $200.2 million in Q1 2026, $100.2 million in Q4 2025, and $100.2 million in Q3 2025.